ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals

Completed · Phase 3

Conditions studied: Opiate Dependence

In brief

The purpose of this study is to determine the safety and tolerability of Medisorb® naltrexone (VIVITROL®) when administered over a period of 24 months to health care professionals who have a history of opioid dependence.

Key facts

Study ID

NCT00834080

Run by

Alkermes, Inc.

People needed

38

Starts

2009-03-01

Expected to finish

2012-05-01

Last updated by the study team

2018-12-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Alkermes Clinical Study Site — Colton, California, United States
• Alkermes Clinical Study Site — Oceanside, California, United States
• Alkermes Clinical Study Site — Lauderhill, Florida, United States
• Alkermes Clinical Study Site — Hoffman Estates, Illinois, United States
• Alkermes Clinical Study Site — St Louis, Missouri, United States
• Alkermes Clinical Study Site — Elmsford, New York, United States
• Alkermes Clinical Study Site — Canton, Ohio, United States
• Alkermes Clinical Study Site — Philadelphia, Pennsylvania, United States
• Alkermes Clinical Study Site — Philadelphia, Pennsylvania, United States
• Alkermes Clinical Study Site — Austin, Texas, United States
• Alkermes Clinical Study Site — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.